Abbreviations:AC (anticholinergics), BoNT (botulinum toxin), CC (catheterizable channel), CIC (clean intermittent catheterization), CP (cerebral palsy), DO (detrusor overactivity), DSD (detrusor sphincter dyssynergia), GMFCS (Gross Motor Function Classification System), NDO (neurogenicdetrusor overactivity), UDS (urodynamics), UUI (urge urinary incontinence)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Cerebral palsy: what parents and doctors want to know.BMJ. 2003; 326: 970-974https://doi.org/10.1136/bmj.326.7396.970
- Aging with cerebral palsy.Phys Med Rehabil Clin North Am. 2005; 16: 235-249https://doi.org/10.1016/j.pmr.2004.06.014
- Correlation between motor function and lower urinary tract dysfunction in patients with infantile cerebral palsy.Neurourol Urodyn. 2007; 26 (PMID:17009254): 222-227https://doi.org/10.1002/nau.20329
- Urodynamic findings in adults with moderate to severe cerebral palsy.Urology. 2016; 95: 216-221
- Urodynamic findings in children with cerebral palsy.Int J Urol. 2005; 12 (PMID:16174044): 717-720https://doi.org/10.1111/j.1442-2042.2005.01120.x
- Neurogenic lower urinary tract dysfunction in adults with cerebral palsy: outcomes following a conservative management approach.J Urol. 2016; 195 (1009-1013 9)
- Bladder changes after catheterizable channel creation in adults with cerebral palsy who are in chronic urinary retention.Neurourol Urodynamics. 2018; 38: 165-170https://doi.org/10.1002/nau.23818
Conflict of interest: None.
Financial Disclosure: The authors declare that they have no relevant financial.
SPE: consultant and speaker for Boston Scientific, PI of clinical trial and consultant for urotronic, investment interest for percuvision.